Insulin exerts direct, IGF-1 independent actions in growth plate chondrocytes

Bone Research

Volumn 2, Issue , 2014, Pages

  Zhang, Fengjie ^a,b   He, Qiling ^c   Tsang, Wing Pui ^a,b   Garvey, W Timothy ^c   Chan, Wai Yee ^a,b   Wan, Chao ^a,b  

^a Prince of Wales Hospital   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84923854878     PISSN: 20954700     EISSN: 20956231     Source Type: Journal    
DOI: 10.1038/boneres.2014.12     Document Type: Article

References (35)

1. Fulzele K, Clemens TL. Novel functions for insulin in bone. Bone 2012; 50: 452-456.
2. Nef S, Parada LF. Hormones in male sexual development. GenesDev 2000; 14: 3075-3086.
3. Ebina Y, Ellis L, Jarnagin K et al. The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signaling. Cell 1985; 40: 747-758.
4. Kim JJ, Accili D. Signalling through IGF-1 and insulin receptors: where is the specificity? Growth Horm IGF Res 2002; 12: 84-90.
5. Woods KA, Camacho-Hubner C, Savage MO, Clark AJ. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor i gene.N Engl JMed 1996; 335: 1363-1367
6. Wang YM, Nishida S, Sakata T et al. Insulin-like growth factor-I is essential for embryonic bone development. Endocrinology 2006; 147: 4753-4761.
7. Baker J, Liu JP, Robertson EJ, Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 1993; 75: 73-82.
8. Govoni KE, Lee SK, Chung YS et al. Disruption of insulin-like growth factor-I expression in type IIalphaI collagen-expressing cells reduces bone length and width in mice. Physiol Genomics 2007; 30: 354-362.
9. Wertheimer E, Lu SP, Backeljauw PF, Davenport ML, Taylor SI. Homozygous deletion of the human insulin receptor gene results in leprechaunism. Nat Genet 1993; 5: 71-73.
10. Accili D, Drago J, Lee EJ et al. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat Genet 1996; 12: 106-109.
11. Bailyes EM, Nave BT, Soos MA, Orr SR, Hayward AC, Siddle K. Insulin receptor/IGF-I receptor hybrids are widely distributed in mammalian tissues: quantification of individual receptor species by selective immunoprecipitation and immunoblotting. Biochem J 1997; 327(Pt 1) : 209-215.
12. Fulzele K, DigirolamoDJ, Liu Z,Xu J,Messina JL, Clemens TL. Disruption of the insulin-like growth factor type 1 receptor in osteoblasts enhances insulin signaling and action. J Biol Chem 2007; 282: 25649-25658.
13. Long F, Joeng KS, Xuan S, Efstratiadis A, McMahon AP. Independent regulation of skeletal growth by Ihh and IGF signaling. Dev Biol 2006; 298: 327-333.
14. Chan SJ, Plisetskaya EM, Urbinati E, Jin Y, Steiner DF. Expression of multiple insulin and insulin-like growth factor receptor genes in salmon gill cartilage. Proc Natl Acad Sci USA 1997; 94: 12446-12451.
15. Hill DJ, De SD. Insulin is a mitogen for isolated epiphyseal growth plate chondrocytes from the fetal lamb. Endocrinology 1990; 126: 2661-2670.
16. Serra R, Chang C. TGF-beta signaling in human skeletal and patterning disorders. Birth Defects Res C Embryo Today 2003; 69: 333-351.
17. Efstratiadis A. Genetics of mouse growth. Int J Dev Biol 1998; 42: 955-976.
18. Ornitz DM, Marie PJ. FGF signaling pathways inendochondral and intramembranous bone development and human genetic disease. Genes Dev 2002; 16: 1446-1465.
19. Treadway JL, Frattali AL, Pessin JE. Intramolecular subunit interactions between insulin and insulin-like growth factor 1 alpha beta half-receptors induced by ligand and Mn/MgATP binding. Biochemistry 1992; 31: 11801-11805.
20. Belfiore A, Frasca F, Pandini G, Sciacca L, Vigneri R. Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. Endocr Rev 2009; 30: 586-623.
21. Brüning JC, Michael MD, Winnay JN et al. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell 1998; 2: 559-569.
22. Baffi MO, Slattery E, Sohn P, Moses HL, Chytil A, Serra R. Conditional deletion of the TGF-beta type II receptor in Col2a expressing cells results in defects in the axial skeleton without alterations in chondrocyte differentiation or embryonic development of long bones. Dev Biol 2004; 276: 124-142.
23. Kulkarni RN, Bruning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR. Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 1999; 96: 329-339.
24. Chen M, Lichtler AC, Sheu TJ et al . Generation of a transgenic mouse model with chondrocyte-specific and tamoxifen-inducible expression of Cre recombinase. Genesis 2007; 45: 44-50.
25. Wang Y, Wan C, Deng L et al. The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Invest 2007; 117: 1616-1626.
26. Inoki K, Zhu TQ, Guan KL. TSC2 mediates cellular energy response to control cell growth and survival. Cell 2003; 115: 577-590.
27. Phornphutkul C, Wu KY, Gruppuso PA. The role of insulin inchondrogenesis. Mol Cell Endocrinol 2006; 249: 107-115.
28. Phorphutkul C, Wu KY, Yang X, Chen Q, Gruppuso PA. Insulin-like growth factor-1 signaling is modified during chondrocyte differentiation. J Endocrinol 2004; 183: 477-486.
29. Böhni R, Riesgo-Escovar J, Oldham S et al. Autonomous control of cell and organ size by CHICO, a Drosophila homolog of vertebrate IRS1-4. Cell 1999; 97: 865-875.
30. Verdu J, Buratovich MA, Wilder EL, Birnbaum MJ. Cell-autonomous regulation of cell and organ growth in Drosophila by AKT/PKB. Nat Cell Biol 1999; 1: 500-506.
31. Johnston LA, Gallant P. Control of growth and organ size in Drosophila. Bioessays 2002; 24: 54-64.
32. Jewell JL, Guan KL. Nutrient signaling to mTOR and cell growth. Trends Biochem 2013; 38: 233-242.
33. Sasaki AT, Firtel RA. Regulation of chemotaxis by the orchestrated activationof Ras, PI3K, and TOR. Eur J Cell Biol 2006; 85: 873-895.
34. Howell JJ, Manning BD. mTOR couples cellular nutrient sensing to organismal metabolic homeostasis. Trends Endocrinol Metab 2011; 22: 94-102.
35. Inoki K, Li Y, Zhu TQ, Wu J, Guan KL. TSC2 is phosphorylated and inhibited by AKT and suppresses mTOR signaling. Nat Cell Biol 2002; 4: 648-657.